203724-40-7

Basic information

• Product Name: (R)-6-(4-nitrophenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
• Synonyms: (R)-6-(4-nitrophenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
• CAS NO: 203724-40-7
• Molecular Weight: 359.387
• Mol File: 203724-40-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (R)-6-(4-nitrophenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-6-(4-nitrophenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine(203724-40-7)
• EPA Substance Registry System: (R)-6-(4-nitrophenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine(203724-40-7)

Safety Data

• Hazardous Substances Data: 203724-40-7(Hazardous Substances Data)

Upstream product

• 187724-90-9 4-chloro-6-(4-nitro-phenyl)-7H-pyrrolo[2,3-d]pyrimidine 
• 3886-69-9 (R)-1-phenyl-ethyl-amine 

Downstream Products

• 187723-66-6 (R)-6-(4-amino-phenyl)-4-[(1-phenyl-ethyl)-amino]-7H-pyrrolo[2,3-d]pyrimidine 

Relevant articles and documents

FUSED BICYCLIC PYRIMIDINES AS PTK INHIBITORS CONTAINING A ZINC BINDING MOIETY

The present invention relates to fused bicyclic pyrimidine containing zinc- binding moiety based derivatives that have unique properties as protein tyrosine kinase (PTK) inhibitors and their use in the treatment of PTK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.